Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Fixed Capital/Sales(x) 2.061.311.361.291.18

What is the latest Fixed Capital/Sales ratio of BIOCON ?

The latest Fixed Capital/Sales ratio of BIOCON is 2.06 based on Mar2023 Consolidated results.
Year Fixed Capital/Sales
Mar20232.06
Mar20221.31
Mar20211.36
Mar20201.29
Mar20191.18

How is Fixed Capital/Sales of BIOCON Trending?

Years Fixed Capital/Sales % Change
Mar2023 2.06
57.25
Mar2022 1.31
-3.68
Mar2021 1.36
5.43
Mar2020 1.29
9.32
Mar2019 1.18 -

Other Financial Ratios of BIOCON


Compare Fixed Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹36,234.1 Cr -0.6% 13.1% 33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,026.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -1.9% 10.7% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 1.6% 1.6% 27.6% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 5.2% -0.2% 90.1% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-0.6%

13.1%

33.6%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses